$0.37
▼ $-0.04
(-9.47%)
Vol 1.1M
3
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$20.7M
ROE
-67.0%
D/E
6.77
Beta
1.27
52W
$1–$2
Price Chart
Similar Stocks
Earnings
Beat rate: 0.0%
Next Report
May 13, 2026
| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Sep 2026 | — | — | — |
| Jun 2026 | — | $-0.08 | — |
Fundamentals Trend
| Metric | 2024-12-31 | 2025-03-31 | 2025-06-30 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -98.3% | -67.0% | — | -67.2% | -67.0% | -67.0% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | 6.26 | 6.77 | — | 6.77 | 6.77 | 6.77 |
| Current Ratio | 0.06 | 0.13 | 0.04 | 0.04 | 0.04 | 0.04 |
Key Ratios
ROA (TTM)
-214.8%
EPS (TTM)
$-7.51
52W High
$1.66
52W Low
$0.81
$0.81
52-Week Range
$1.66
How does LNAI compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
LNAI valuation vs Biotechnology peers
P/E ratio
—
▼
0%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
—
▼
0%
below
peers
(12.9)
vs Peers
vs Industry
Overvalued
P/B ratio
—
▼
0%
below
peers
(2.5)
vs Peers
vs Industry
Overvalued
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
LNAI profitability vs Biotechnology peers
ROE
-67.0%
▲
0%
above
peers
(-67.3%)
vs Peers
vs Industry
In line
Net margin
—
▼
0%
below
peers
(-286.8%)
vs Peers
vs Industry
Top tier
Gross margin
—
▼
0%
below
peers
(78.6%)
vs Peers
vs Industry
In line
ROA
-214.8%
▼
360%
below
peers
(-46.7%)
vs Peers
vs Industry
Weak
LNAI financial health vs Biotechnology peers
D/E ratio
6.8
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
High debt
Current ratio
0.0
▼
99%
below
peers
(4.4)
vs Peers
vs Industry
Low liquidity
Beta
1.3
▲
31%
above
peers
(1.0)
vs Peers
vs Industry
More volatile
LNAI fundamentals radar
LNAI
Peer median
Industry
LNAI profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
LNAI vs peers: key metrics
Latest News
No related news yet